[ Price : $8.95]
FDA says that conflicting results in new studies make it premature to reach a conclusion about a possible link between SSRI antide...[ Price : $8.95]
Harvard professor Daniel Carpenter calls for an independent FDA similar to the Federal Reserve to avoid future presidential interf...[ Price : $8.95]
FDA gives Pinnacle Biologics Photofrin orphan drug status as adjuvant therapy for malignant pleural mesothelioma.[ Price : $8.95]
The Center for Reproductive Rights says it will reopen a 2005 lawsuit against FDA for maintaining unnecessary age restrictions on ...[ Price : $8.95]
FDA releases safety labeling changes approved in November for 48 drug products, including a new Warning and Precaution for 11 HIV/...[ Price : $8.95]
Repros Therapeutics says it met with CDER Divisions of Urologic and Endocrinologic Products to gain input on designing a Phase 3 t...[ Price : $8.95]
ViroPharma says FDA approval of a sNDA for new labeling information for its Vancocin meets agency requirements for three years of ...[ Price : $8.95]
Vertex and Alios say they are starting Phase 1 trials of two nucleotide analogs to determine their safety and tolerability for pot...